Virus Capture Kits

Get more from your samples and get it faster. Knowing a virus is present in a sample and not being able to detect it is frustrating. Use Nanotrap® Magnetic Virus Particles to concentrate viruses rapidly from complex biological matrices in order to have high quality input material for your downstream analytical methods.

Application Notes

Protocols

E-Book

Posters and Publications

Product Brochure

ORDER

PRODUCT DESCRIPTION

Nanotrap® Magnetic Virus Particles demonstrated to capture and concentrate the following viruses: influenza A H1N1 (1), influenza A H3N2 (1), influenza B (1), respiratory syncytial virus A2001/3-12 (1), coronavirus 229E (1), coronavirus OC43 (2), SARS-CoV-2 (3)(4), Zika (10), chikungunya (10), pepper mottle virus (12),

Methods developed for clinical swab samples, saliva, and wastewater. (3)(4)(7)(8)

Enables an automated method for concentrating and processing virus from 24 raw wastewater samples in 40 minutes, reducing processing time by at least 20-fold, as compared to other methods. (8)

Wastewater processing protocols available for manual or automated workflows.

Combine with Nanotrap® Enhancement Reagent to improve Ct values by at least 1-2 in your wastewater samples.

Reduce clinical sample processing time by 2- to 3-fold by eliminating commercial extraction kit.

Enables pooled patient sample testing with methods developed for sample volumes up to 10 mL. (4)(6)

Eliminate false negatives. Nanotrap® particles enabled the identification of SARS-CoV-2 RNA in 9 out of 32 diagnostic remnant samples that had previously tested negative for the virus. (4)

Increase assay sensitivity by capturing and concentrating low abundance viruses. Nanotrap® particles improved the real-time RT-PCR signal in low viral load diagnostic remnant samples by an average of 3.1 Ct values. (4)

Successfully utilized in RT-PCR assays with FDA Emergency Used Authorization for COVID-19. (9)(11)

Nanotrap® particles utilize affinity capture and enrichment to attract and bind low abundance viruses. Nanotrap® particles do not utilize antibodies or other biomolecules as affinity molecules.

For Research Use Only. Not for use in diagnostic procedures.

Incorporating the Nanotrap® technology into your workflow is simple. Reduce your sample real-time RT-PCR sample processing time by 2-3 fold by eliminating a commercial extraction kit altogether.